SCHEMBL6567482

SCHEMBL6567482

O=C1c2ccccc2C(=O)N1CCOc1cc(F)ccc1O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.62
NPC1 O15118 4/20 0.62
TSHR P16473 3/20 0.58
HPGD P15428 3/20 0.58
ALDH1A1 P00352 2/20 0.54
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
LMNA P02545 1/20 0.47
AGTR1 P30556 1/20 0.47
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9631943 0.83 RAB9A (0.60) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL9633041 0.83 RAB9A (0.60) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL6566423 0.82 RAB9A (0.60) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL9632000 0.82 RAB9A (0.59) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL9633218 0.82 RAB9A (0.59) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL9632462 0.81 RAB9A (0.61) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL6565574 0.80 L3MBTL1 (0.59) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL4713152 0.80 ALDH1A1 (0.64) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL11638432 0.78 RAB9A (0.54) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL1677061 0.77 RAB9A (1.00) RAB9ANPC1TSHRHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135360-B1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PF MEDICAMENT (FR) 2004-03-31 EP disclosed
EP-1187824-B1 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PF MEDICAMENT (FR) 2002-11-13 EP disclosed
US-6417222-B1 DRUGS FOR PSYCHOLOGICAL DISORDERS OR COGNITION ACTIVATORS PIERRE FABRE MEDICAMENT (FR) 2002-07-09 US disclosed
EP-1187824-A2 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2002-03-20 EP disclosed
US-6350913-B1 AROMATIC AMINE COMPOUNDS PIERRE FABRE MEDICAMENT (FR) 2002-02-26 US disclosed
EP-1135360-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2001-09-26 EP disclosed
WO-2000058282-A2 NOVEL [(2-SUBSTITUTED-5 -[3-THIENYL) -BENZYL]-[2- ([2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2000-10-05 WO disclosed
WO-2000032557-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2000-06-08 WO disclosed